| Literature DB >> 25869605 |
H Zhu1, J Bhagatwala2, N K Pollock1, S Parikh2, B Gutin1, I Stallmann-Jorgensen3, J Thomas1, G A Harshfield1, Y Dong1.
Abstract
BACKGROUND/Entities:
Mesh:
Substances:
Year: 2015 PMID: 25869605 PMCID: PMC6344938 DOI: 10.1038/ijo.2015.51
Source DB: PubMed Journal: Int J Obes (Lond) ISSN: 0307-0565 Impact factor: 5.095
General characteristics of study participants
| Total sample | Normal weight | Overweight/obese | ||
|---|---|---|---|---|
| 766 | 575 | 191 | ||
| Age (y) | 16.1 ± 0.0 | 16.1 ± 0.1 | 16.2 ± 0.1 | 0.44 |
| Female (%) | 50.3 | 49.2 | 53.4 | 0.32 |
| African Americans (%) | 49.2 | 43.8 | 65.4 | <0.01 |
| Tanner stage | 4.3 ± 0.0 | 4.3 ± 0.0 | 4.4 ± 0.1 | 0.04 |
| SES | 41.2 ± 0.6 | 41.2 ± 0.6 | 41.0 ± 1.2 | 0.88 |
| Moderate/vigorous physical activity (min/d) | 43.9 ± 1.1 | 43.4 ± 1.1 | 45.5 ± 2.0 | 0.37 |
| Moderate physical activity (min/d) | 39.1 ± 0.9 | 38.3 ± 0.9 | 41.6 ± 1.6 | 0.08 |
| Vigorous physical activity (min/d) | 4.8 ± 0.3 | 5.1 ± 0.3 | 3.9 ± 0.5 | 0.05 |
| Dietary intake | ||||
| Energy (kcal/d) | 1956.5 ± 21.5 | 1978.6 ± 22.6 | 1885.9 ± 39.5 | 0.04 |
| Sodium (mg/d) | 3280.5 ± 41.5 | 3221.2 ± 23.1 | 3270.9 ± 40.4 | 0.29 |
| Telomere length (T/S) | 1.29 ± 0.01 | 1.29 ± 0.01 | 1.28 ± 0.02 | 0.50 |
SES, socioeconomic status; Values are age, sex and race adjusted means ± SE.
Tests of significance between groups were conducted by analysis of covariance (controlling for age, race and sex).
Tests of significance between groups were based on the χ2 test.
Tests of significance between groups were conducted by using analysis of covariance (controlling for age, race, sex and energy intake).
Figure 1Differences in leukocyte telomere length based on obesity and sodium intake. Telomere length is plotted as T/S ratio. The values are mean ± SE.